Related Experiment Videos
The Akt of translational control
Davide Ruggero1, Nahum Sonenberg
1Human Genetics Program, Fox Chase Cancer Center, PA 19111, USA. davide.ruggero@fccc.edu
Oncogene
|November 17, 2005
Summary
The oncogene AKT (also called protein kinase B (PKB)) regulates protein synthesis, and its abnormal activation is linked to cancer. Deregulation of protein synthesis by AKT may drive tumor formation, highlighting a key mechanism in cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- The oncogene AKT (protein kinase B, PKB) plays a critical role in cell signaling pathways.
- AKT activation influences protein synthesis, impacting cell growth, proliferation, and survival.
- Aberrant AKT signaling is frequently observed in various cancers.
Purpose of the Study:
- To review the molecular and genetic evidence linking AKT-mediated protein synthesis control to cancer.
- To discuss the role of aberrant protein synthesis in tumorigenesis.
- To highlight future challenges in identifying specific mRNA targets regulated by AKT in cancer.
Main Methods:
- Literature review of molecular and genetic studies.
- Analysis of evidence supporting AKT's role in translation.
- Discussion of conserved mechanisms from Drosophila to humans.
Main Results:
- AKT directly stimulates translation initiation factors and ribosome biogenesis.
- Aberrant AKT activation leading to protein synthesis defects is a conserved mechanism.
- Evidence suggests a crucial role for translation control in cancer development.
Conclusions:
- Deregulation of protein synthesis by AKT is a significant contributor to cancer formation.
- Identifying specific AKT-regulated mRNAs is crucial for understanding tumorigenesis.
- Targeting protein synthesis control pathways may offer novel cancer therapies.